How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

The Democratic Socialists of America rail against the one percent, but close to a third of them are clearing six-figure incomes a year, according to a newly surfaced internal survey. As many as 28% of ...

A member of the Los Angeles City Council who called for a permanent cease-fire in the Israel-Hamas war won the support of a pro-Israel group, sparking infighting in the leftist organization that ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

California’s Democratic Socialists have made their pick for governor — but they’re not happy about it. The nation’s largest socialist organization grudgingly threw its weight behind billionaire Tom ...

The Digital Services Act (DSA) is the world’s first digital regulation that makes digital companies across the EU accountable for the content posted on their platforms. On this page What is the ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...